Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
17 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/17/3101007/0/en/BioAegis-Therapeutics-Receives-FDA-Fast-Track-Designation-for-Lead-Product-Recombinant-Human-Gelsolin-for-the-Treatment-of-Acute-Respiratory-Distress-Syndrome-ARDS.html
10 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/10/3097181/0/en/BioAegis-Therapeutics-Announces-US-Navy-Contract-to-Support-Phase-2-Study-of-Recombinant-Human-Gelsolin-for-Inflammasome-Driven-Decompression-Sickness-DCS.html
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3075697/0/en/BioAegis-Therapeutics-Announces-Site-Activation-and-Patient-Recruitment-Underway-in-13-Countries-in-Phase-2b-Clinical-Trial-of-Gelsolin-an-Immune-Regulator-for-the-Treatment-of-Acu.html
18 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/18/3044897/0/en/BioAegis-Therapeutics-to-Highlight-Lead-Product-Gelsolin-s-Critical-Role-in-Immune-Function-at-Upcoming-Conferences.html
22 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/22/2966612/0/en/BioAegis-Therapeutics-Enrolls-First-Patient-in-Phase-2-Clinical-Trial-of-Gelsolin-an-Immune-Regulator-for-the-Treatment-of-Acute-Respiratory-Distress-Syndrome-ARDS.html
17 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/17/2964846/0/en/BioAegis-Therapeutics-Enrolls-First-Patient-in-Phase-2-Clinical-Trial-of-Gelsolin-an-Immune-Regulator-for-the-Treatment-of-Acute-Respiratory-Distress-Syndrome-ARDS.html
ABOUT THIS PAGE